Table of Contents
As the days grow shorter and temperatures drop, a familiar concern returns: the surge in respiratory illnesses.Many individuals are currently questioning whether their symptoms signal a common cold, influenza, or a COVID-19 infection. The Robert koch Institute (RKI) reports a “low to moderate” wave of respiratory diseases, offering guidance on how to best protect yourself and others.
Current State of Respiratory Infections
According to the RKI’s latest weekly report, the number of acute respiratory illnesses is currently declining, but remains at a significant level. Extrapolating data from voluntary reports, the institute estimates approximately 5,800 illnesses per 100,000 inhabitants, a slight decrease from the 6,100 reported the previous week. This translates to roughly 4.9 million acute respiratory diseases across the country, as of the week of October 27th to November 2nd.
COVID-19 Activity remains below Previous Levels
While COVID-19 cases have not continued to rise, the RKI reports an estimated incidence of around 200 cases per 100,000 inhabitants during the week in question – a notable drop from the approximately 400 cases reported the prior week. This level of activity remains considerably lower than the figures observed during the same period last year, which stood around 800 cases per 100,000. The RKI cautions that numbers may fluctuate due to the autumn school holidays.
The Dominant Strain: XFG (Stratus)
Currently, the XFG lineage, also known as Stratus, is the most prevalent variant of the virus causing COVID-19 in Germany.
Guidance for Those Who Are Sick
Individuals experiencing symptoms of a cold, flu, or COVID-19 are advised to stay home for three to five days, or until symptoms have significantly improved, according to the BIÖG. Direct contact with others should be minimized, especially with those at higher risk of severe illness, including infants, the elderly, individuals with pre-existing conditions, those with compromised immune systems, and pregnant women.
When to Seek Medical Attention
If symptoms do not improve or worsen after several days, consulting a doctor is recommended.This includes instances of high fever or signs of a bacterial infection, such as purulent nasal discharge, or a cough producing sputum, painful cough, shortness of breath, or rapid breathing, which could indicate pneumonia. Individuals in high-risk groups should seek medical advice promptly if they experience any symptoms of a respiratory infection.
Protective measures Remain Important
Protective measures that gained prominence during the COVID-19 pandemic remain effective. These include regular ventilation, thorough hand washing, and the use of masks. The BIÖG recommends that individuals in risk groups consider wearing masks for self-protection. Mask-wearing is also advised for those with a respiratory infection to protect others, especially when close contact with vulnerable individuals is unavoidable. Studies have demonstrated that masks significantly reduce the spread of respiratory viruses and lower the risk of infection.When coughing or sneezing, individuals should use a tissue or the crook of their arm, turning away from others.
vaccination: A Key Defense
The most effective protection against severe illness remains vaccination against influenza, COVID-19, and the respiratory syncytial virus (RSV). The Standing Vaccination Commission (Stiko) recommends booster vaccinations for individuals aged 60 and over, and those with underlying health conditions, for both COVID-19 and influenza this autumn. The COVID-19 vaccine is also effective against the Stratus variant. Stiko also recommends a one-time RSV vaccination for individuals aged 75 and over, and those aged 60 to 74 with serious underlying conditions.
Medication Supply Remains Stable
The Federal Institute for Drugs and Medical Devices reports a stable supply of medication for the autumn and winter seasons. The situation has improved in recent years due to the Drug Supply Bottleneck Combating and Supply Improvement Act, enacted in July 2023. While approximately 500 supply bottlenecks exist among the 100,000 approved medicines in Germany, significant shortages are rare. Pharmacists are typically able to find suitable alternatives when faced with delivery bottlenecks.
Sources used: dpa news agency, RKI weekly report.
